STK11 and neoplasm: KRAS mutations were detected in 49 (16% in the whole tumour set, 25% in Caucasian and 8% in Asian specimens) tumour specimens with 10 (20% of KRAS mutants) of these occurring concurrently with an LKB1 mutation (P=0.042) (Table 3).